» Authors » Aaron G Day-Williams

Aaron G Day-Williams

Explore the profile of Aaron G Day-Williams including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 2108
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Iwaki H, Blauwendraat C, Leonard H, Makarious M, Kim J, Liu G, et al.
Mov Disord . 2020 Oct; 36(1):106-117. PMID: 33002231
Background: Previous studies reported various symptoms of Parkinson's disease (PD) associated with sex. Some were conflicting or confirmed in only one study. Objectives: We examined sex associations to PD phenotypes...
2.
Leonard H, Blauwendraat C, Krohn L, Faghri F, Iwaki H, Ferguson G, et al.
J Med Genet . 2019 Dec; 57(5):331-338. PMID: 31784483
Background: Classical randomisation of clinical trial patients creates a source of genetic variance that may be contributing to the high failure rate seen in neurodegenerative disease trials. Our objective was...
3.
Iwaki H, Blauwendraat C, Leonard H, Kim J, Liu G, Maple-Grodem J, et al.
Mov Disord . 2019 Sep; 34(12):1839-1850. PMID: 31505070
Background: Several reports have identified different patterns of Parkinson's disease progression in individuals carrying missense variants in GBA or LRRK2 genes. The overall contribution of genetic factors to the severity...
4.
Iwaki H, Blauwendraat C, Leonard H, Liu G, Maple-Grodem J, Corvol J, et al.
Neurol Genet . 2019 Aug; 5(4):e348. PMID: 31404238
Objective: To determine if any association between previously identified alleles that confer risk for Parkinson disease and variables measuring disease progression. Methods: We evaluated the association between 31 risk variants...
5.
Bodea C, Mitchell A, Bloemendal A, Day-Williams A, Runz H, Sunyaev S
Genome Biol . 2018 Oct; 19(1):173. PMID: 30359302
Functional characterization of the noncoding genome is essential for biological understanding of gene regulation and disease. Here, we introduce the computational framework PINES (Phenotype-Informed Noncoding Element Scoring), which predicts the...
6.
Diogo D, Tian C, Franklin C, Alanne-Kinnunen M, March M, Spencer C, et al.
Nat Commun . 2018 Oct; 9(1):4285. PMID: 30327483
Phenome-wide association studies (PheWAS) have been proposed as a possible aid in drug development through elucidating mechanisms of action, identifying alternative indications, or predicting adverse drug events (ADEs). Here, we...
7.
Estrada K, Whelan C, Zhao F, Bronson P, Handsaker R, Sun C, et al.
Nat Commun . 2018 May; 9(1):1929. PMID: 29769526
Neuromyelitis optica (NMO) is a rare autoimmune disease that affects the optic nerve and spinal cord. Most NMO patients ( > 70%) are seropositive for circulating autoantibodies against aquaporin 4...
8.
Flannick J, Fuchsberger C, Mahajan A, Teslovich T, Agarwala V, Gaulton K, et al.
Sci Data . 2018 Jan; 5:180002. PMID: 29360107
This corrects the article DOI: 10.1038/sdata.2017.179.
9.
Flannick J, Fuchsberger C, Mahajan A, Teslovich T, Agarwala V, Gaulton K, et al.
Sci Data . 2017 Dec; 4:170179. PMID: 29257133
To investigate the genetic basis of type 2 diabetes (T2D) to high resolution, the GoT2D and T2D-GENES consortia catalogued variation from whole-genome sequencing of 2,657 European individuals and exome sequencing...
10.
Panoutsopoulou K, Thiagarajah S, Zengini E, Day-Williams A, Ramos Y, Meessen J, et al.
Ann Rheum Dis . 2016 Dec; 76(7):1199-1206. PMID: 27974301
Objective: Osteoarthritis (OA) has a strong genetic component but the success of previous genome-wide association studies (GWAS) has been restricted due to insufficient sample sizes and phenotype heterogeneity. Our aim...